The German government's global health strategy – a strategy also to support research and development for neglected diseases?

Fehr A, Razum O (2014)
Global Health Action 7: 1-3.

Download
OA
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Volltext vorhanden für diesen Nachweis
Autor/in
;
Abstract / Bemerkung
Neglected tropical infectious diseases as well as rare diseases are characterized by structural research and development (R&D) deficits. The market fails for these disease groups. Consequently, to meet public health and individual patient needs, political decision makers have to develop strategies at national and international levels to make up for this R&D deficit. The German government recently published its first global health strategy. The strategy underlines the German government’s commitment to strengthening global health governance. We find, however, that the strategy lacks behind the international public health endeavors for neglected diseases. It fails to make reference to the ongoing debate on a global health agreement. Neither does it outline a comprehensive national strategy to promote R&D into neglected diseases, which would integrate existing R&D activities in Germany and link up to the international debate on sustainable, needs-based R&D and affordable access. This despite the fact that only recently, in a consensus-building process, a National Plan of Action for rare diseases was successfully developed in Germany which could serve as a blueprint for a similar course of action for neglected diseases. We recommend that, without delay, a structured process be initiated in Germany to explore all options to promote R&D for neglected diseases, including a global health agreement.
Erscheinungsjahr
Zeitschriftentitel
Global Health Action
Band
7
Seite(n)
1-3
ISSN
eISSN
Finanzierungs-Informationen
Article Processing Charge funded by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University.
PUB-ID

Zitieren

Fehr A, Razum O. The German government's global health strategy – a strategy also to support research and development for neglected diseases? Global Health Action. 2014;7:1-3.
Fehr, A., & Razum, O. (2014). The German government's global health strategy – a strategy also to support research and development for neglected diseases? Global Health Action, 7, 1-3. doi:10.3402/gha.v7.24565
Fehr, A., and Razum, O. (2014). The German government's global health strategy – a strategy also to support research and development for neglected diseases? Global Health Action 7, 1-3.
Fehr, A., & Razum, O., 2014. The German government's global health strategy – a strategy also to support research and development for neglected diseases? Global Health Action, 7, p 1-3.
A. Fehr and O. Razum, “The German government's global health strategy – a strategy also to support research and development for neglected diseases?”, Global Health Action, vol. 7, 2014, pp. 1-3.
Fehr, A., Razum, O.: The German government's global health strategy – a strategy also to support research and development for neglected diseases? Global Health Action. 7, 1-3 (2014).
Fehr, Angela, and Razum, Oliver. “The German government's global health strategy – a strategy also to support research and development for neglected diseases?”. Global Health Action 7 (2014): 1-3.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Copyright Statement:
This Item is protected by copyright and/or related rights. [...]
Volltext(e)
Access Level
OA Open Access
Zuletzt Hochgeladen
2019-09-06T09:18:25Z

1 Zitation in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Advancing Germany's new global health strategy.
Stratil JM, von Philipsborn P, Marckmann G, Pfadenhauer LM, Zeeb H, Rehfuess EA., BMJ Glob Health 3(6), 2018
PMID: 30613429

28 References

Daten bereitgestellt von Europe PubMed Central.

Shaping global health – taking joint action – embracing responsibility
AUTHOR UNKNOWN, 2014
Germany and global health: an unfinished agenda?
Bozorgmehr K, Bruchhausen W, Hein W, Knipper M, Korte R, Tinnemann P, Razum O., Lancet 382(9906), 2013
PMID: 24267997
Macroeconomics and health: investing in health for economic development
AUTHOR UNKNOWN, 2011
Public health, innovation and intellectual property rights
AUTHOR UNKNOWN, 2006
Closing the gap in a generation. Health equity through action on the social determinants of health
AUTHOR UNKNOWN, 2008
Editorial: drug development for neglected diseases: a public health challenge.
Fehr A, Thurmann P, Razum O., Trop. Med. Int. Health 11(9), 2006
PMID: 16930253
Research and development to meet health needs in developing countries: strengthening global financing and coordination
AUTHOR UNKNOWN, 2012
Medical Research and Development Treaty (MRDT)
AUTHOR UNKNOWN, 2005
Review of CPTech proposal for an R&D treaty
Orsenigo L., 2005
Reply to the comments requested by CIPIH and WHO to the CPTech proposal for a Medical Research and Development Treaty (MRDT)
Hubbard T., 2005
A Global Medical Research and Development Treaty
Farlow A., 2007
The idea of a convention for global health.
Haffeld J, Heggenhougen HK, Lie SO, Rottingen JA, Schei B., Tidsskr. Nor. Laegeforen. 131(18), 2011
PMID: 21946599
The Joint Action and learning initiative: towards a global agreement on national and global responsibilities for health.
Gostin LO, Friedman EA, Ooms G, Gebauer T, Gupta N, Sridhar D, Chenguang W, Rottingen JA, Sanders D., PLoS Med. 8(5), 2011
PMID: 21572991
A framework convention on global health: a catalyst for justice.
Sidibe M, Buse K., Bull. World Health Organ. 90(12), 2012
PMID: 23284188
Towards a Framework Convention on Global Health: a transformative agenda for global health justice.
Gostin LO, Friedman EA., Yale J Health Policy Law Ethics 13(1), 2013
PMID: 23815040
Resolution WHA65.22. Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination
AUTHOR UNKNOWN, 2012
Securing the public good of health research and development for developing countries.
Rottingen JA, Chamas C, Goyal LC, Harb H, Lagrada L, Mayosi BM., Bull. World Health Organ. 90(5), 2012
PMID: 22589577
Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?
Rottingen JA, Regmi S, Eide M, Young AJ, Viergever RF, Ardal C, Guzman J, Edwards D, Matlin SA, Terry RF., Lancet 382(9900), 2013
PMID: 23697824
National and global responsibilities for health.
Gostin LO, Heywood M, Ooms G, Grover A, Rottingen JA, Chenguang W., Bull. World Health Organ. 88(10), 2010
PMID: 20931051
Pharmaindustrie erfindet die Zivilgesellschaft neu
AUTHOR UNKNOWN, 2013
Nationaler Aktionsplan für Menschen mit Seltenen Erkrankungen
AUTHOR UNKNOWN, 2013
Expert Delphi survey on research and development into drugs for neglected diseases.
Fehr A, Thurmann P, Razum O., BMC Health Serv Res 11(), 2011
PMID: 22087801
G-Finder global funding of innovation for neglected diseases
AUTHOR UNKNOWN, 2013

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 25079287
PubMed | Europe PMC

Suchen in

Google Scholar